ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Three Scientists Win Albert Lasker Medial Research Awards

September 30, 1994

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

In Brief: Comis Named ECOG Chairman; Long Joins Capitol Associates; Chabner Day In Shelbyville

April 14, 1995

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979